These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3524587)

  • 1. Immunoelectron-microscopic localization of the terminal C5b-9 complement complex in human atherosclerotic fibrous plaque.
    Rus HG; Niculescu F; Constantinescu E; Cristea A; Vlaicu R
    Atherosclerosis; 1986 Jul; 61(1):35-42. PubMed ID: 3524587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cells carrying C5b-9 complement complexes in human atherosclerotic wall.
    Rus HG; Niculescu F; Poruţiu D; Ghiurca V; Vlaicu R
    Immunol Lett; 1989 Mar; 20(4):305-10. PubMed ID: 2714850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoelectron-microscopic localization of S-protein/vitronectin in human atherosclerotic wall.
    Niculescu F; Rus HG; Poruţiu D; Ghiurca V; Vlaicu R
    Atherosclerosis; 1989 Aug; 78(2-3):197-203. PubMed ID: 2476993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque.
    Vlaicu R; Niculescu F; Rus HG; Cristea A
    Atherosclerosis; 1985 Nov; 57(2-3):163-77. PubMed ID: 3910058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of the terminal C5b-9 complement complex in the human aortic atherosclerotic wall.
    Niculescu F; Rus H; Cristea A; Vlaicu R
    Immunol Lett; 1985; 10(2):109-14. PubMed ID: 3897036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the human terminal complement pathway in atherosclerosis.
    Niculescu F; Rus HG; Vlaicu R
    Clin Immunol Immunopathol; 1987 Nov; 45(2):147-55. PubMed ID: 2444373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical study of the C5b-9 complex of complement in human kidneys.
    Hinglais N; Kazatchkine MD; Bhakdi S; Appay MD; Mandet C; Grossetete J; Bariety J
    Kidney Int; 1986 Sep; 30(3):399-410. PubMed ID: 3537447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C5b-9 terminal complement complex assembly on apoptotic cells in human arterial wall with atherosclerosis.
    Niculescu F; Niculescu T; Rus H
    Exp Mol Pathol; 2004 Feb; 76(1):17-23. PubMed ID: 14738864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical localization of C5b-9, S-protein, C3d and apolipoprotein B in human arterial tissues with atherosclerosis.
    Niculescu F; Rus HG; Vlaicu R
    Atherosclerosis; 1987 May; 65(1-2):1-11. PubMed ID: 2955791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-localization of terminal C5b-9 complement complexes and macrophages in human atherosclerotic arterial walls.
    Rus HG; Niculescu F; Vlaicu R
    Immunol Lett; 1988 Sep; 19(1):27-32. PubMed ID: 3192278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative evaluation of the terminal C5b-9 complement complex by ELISA in human atherosclerotic arteries.
    Niculescu F; Hugo F; Rus HG; Vlaicu R; Bhakdi S
    Clin Exp Immunol; 1987 Aug; 69(2):477-83. PubMed ID: 3652536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between macrophages and C5b-9 complement complexes in human atherosclerosis.
    Rus HG; Niculescu F; Vlaicu R
    Clin Immunol Immunopathol; 1988 Sep; 48(3):307-16. PubMed ID: 3042211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prelesional complement activation in experimental atherosclerosis. Terminal C5b-9 complement deposition coincides with cholesterol accumulation in the aortic intima of hypercholesterolemic rabbits.
    Seifert PS; Hugo F; Hansson GK; Bhakdi S
    Lab Invest; 1989 Jun; 60(6):747-54. PubMed ID: 2659887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex.
    Bariety J; Hinglais N; Bhakdi S; Mandet C; Rouchon M; Kazatchkine MD
    Clin Exp Immunol; 1989 Jan; 75(1):76-81. PubMed ID: 2467771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of the terminal C5b-9 complement complex in children with glomerular diseases.
    Rus HG; Niculescu F; Nanulescu M; Cristea A; Florescu P
    Clin Exp Immunol; 1986 Jul; 65(1):66-72. PubMed ID: 3539428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical localization of the terminal C5b-9 complement complexes associated to S-protein and macrophage immunoreactive deposits in human damaged myocardial areas.
    Vlaicu R; Rus HG; Niculescu F
    Med Interne; 1988; 26(1):21-7. PubMed ID: 3399815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decay-accelerating factor regulates complement-mediated damage in the human atherosclerotic wall.
    Niculescu F; Rus HG; Vlaicu R
    Immunol Lett; 1990 Oct; 26(1):17-23. PubMed ID: 1703512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies against neoantigens of the terminal C5b-9 complex of human complement.
    Hugo F; Jenne D; Bhakdi S
    Biosci Rep; 1985 Aug; 5(8):649-58. PubMed ID: 2415178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C5b-9 deposition in children with glomerular diseases.
    Nanulescu M; Rus HG; Niculescu F; Cristea A; Florescu P
    Med Interne; 1987; 25(2):99-104. PubMed ID: 3303285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of IgG and complement factor C3 in human arterial endothelium and atherosclerotic lesions.
    Hansson GK; Holm J; Kral JG
    Acta Pathol Microbiol Immunol Scand A; 1984 Nov; 92(6):429-35. PubMed ID: 6393703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.